MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image ATALANTA THERAPEUTICS
ATALANTA THERAPEUTICS

ATALANTA THERAPEUTICS

HQ - Boston

Summary

Atalanta Therapeutics is a biopharmaceutical company specializing in pioneering treatments for neurodegenerative diseases.

Deals Overview

Total Deals1
Valued Deals1
Total Value£ 78 M
Avg. Deal Size£ 78 M

Market Context

Senior Management

  • Alicia Secor

    Alicia Secor

    President and CEO

  • Jeff Young

    Jeff Young

    CFO

  • Bart G. Newland

    Bart G. Newland

    General Counsel

Sort

as

alicia secor

President and CEO at ATALANTA THERAPEUTICS

Manager

1

Deal

£ 78 M

Total Value

bg

bart g. newland

General Counsel at ATALANTA THERAPEUTICS

Manager

1

Deal

£ 78 M

Total Value

jy

jeff young

CFO at ATALANTA THERAPEUTICS

Manager

1

Deal

£ 78 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite